Panagora Asset Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Panagora Asset Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,932	Closed	-$500K	–	2457
2017 Q4	$500K	Buy	10,932 +6,732	+160%	+$336K	﹤0.01%	1378
2017 Q3	$188K	Hold	4,200	–	–	﹤0.01%	1710
2017 Q2	$126K	Hold	4,200	–	–	﹤0.01%	1808
2017 Q1	$93K	Hold	4,200	–	–	﹤0.01%	1874
2016 Q4	$79K	Hold	4,200	–	–	﹤0.01%	2011
2016 Q3	$126K	Buy	4,200 +1,490	+55%	+$46.4K	﹤0.01%	1905
2016 Q2	$104K	Hold	2,710	–	–	﹤0.01%	1901
2016 Q1	$103K	Buy	+2,710	New	+$94.4K	﹤0.01%	1856

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Panagora Asset Management's JUNO Position: Q1 2018 in Review

Panagora Asset Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 10,932 shares — an estimated $500K sold.

Panagora Asset Management first reported a position in JUNO in Q1 2016 and held it in 8 quarters. The position peaked at $500K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Panagora Asset Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Panagora Asset Management sold 10,932 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $500K.
Panagora Asset Management first reported a position in Juno Therapeutics, Inc. in Q1 2016 and held it in 8 quarters.
Panagora Asset Management's Juno Therapeutics, Inc. position peaked at $500K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Panagora Asset Management's 13F filing for Q1 2018, filed 15 May 2018.